Biora Therapeutics, Inc.
TREATMENT OF INFLAMMATORY DISEASE USING INGESTIBLE DEVICE TO RELEASE IMMUNE MODULATOR

Last updated:

Abstract:

This disclosure features methods and compositions for treating inflammatory disorders or conditions that arise in a tissue originating from the endoderm using an immune modulator.

Status:
Application
Type:

Utility

Filling date:

13 Aug 2018

Issue date:

15 Oct 2020